MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 - Germany

This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

: MII CM Onko ATC Code Changes 2022 to 2023

Active as of 2024-12-12

Raw xml | Download


<ConceptMap xmlns="http://hl7.org/fhir">
  <id value="mii-cm-onko-atc-transitions-2023"/>
  <meta>
    <extension
               url="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-license">
      <valueCode value="CC-BY-4.0"/>
    </extension>
    <extension url="http://hl7.org/fhir/StructureDefinition/package-source">
      <extension url="packageId">
        <valueId
                 value="de.medizininformatikinitiative.kerndatensatz.onkologie"/>
      </extension>
      <extension url="version">
        <valueString value="2027.0.0-ballot.1"/>
      </extension>
      <extension url="uri">
        <valueUri
                  value="https://www.medizininformatik-initiative.de/fhir/ext/modul-onko"/>
      </extension>
    </extension>
    <profile
             value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareableconceptmap"/>
    <profile
             value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishableconceptmap"/>
  </meta>
  <language value="en"/>
  <text>
    <status value="generated"/>
    <div xml:lang="en" lang="en"><hr/><p><b>English</b></p><hr/><p class="res-header-id"><b>Generated Narrative: ConceptMap mii-cm-onko-atc-transitions-2023</b></p><a name="mii-cm-onko-atc-transitions-2023"> </a><a name="hcmii-cm-onko-atc-transitions-2023"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profiles: <a href="http://hl7.org/fhir/uv/crmi/STU2/StructureDefinition-crmi-shareableconceptmap.html">CRMI Shareable ConceptMap</a>, <a href="http://hl7.org/fhir/uv/crmi/STU2/StructureDefinition-crmi-publishableconceptmap.html">CRMI Publishable ConceptMap</a></p></div><p>Mapping from <a href="ValueSet-mii-vs-onko-systemische-therapie-substanzen-2022.html">MII VS Onkologie Systemische Therapie Substanzen ATC 2022</a> to <a href="ValueSet-mii-vs-onko-systemische-therapie-substanzen-2023.html">MII VS Onkologie Systemische Therapie Substanzen ATC 2023</a></p><br/><p>Mapping from <code>http://fhir.de/CodeSystem/bfarm/atc</code> (Atc) to <code>http://fhir.de/CodeSystem/bfarm/atc</code> (Atc)</p><table class="grid"><tr><td><b>Source Code</b></td><td><b>Relationship</b></td><td><b>Target Code</b></td><td><b>Comment</b></td></tr><tr><td>L01XX70 (Axicabtagen Ciloleucel)</td><td><a href="http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#concept-map-equivalence-equivalent" title="equivalent">is equivalent to</a></td><td>L01XL03 (Axicabtagen Ciloleucel)</td><td>Reklassifizierung zu CAR-T-Zelltherapien</td></tr><tr><td>L01XX51 (Talimogen laherparepvec)</td><td><a href="http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#concept-map-equivalence-equivalent" title="equivalent">is equivalent to</a></td><td>L01XL02 (Talimogen laherparepvec)</td><td>Reklassifizierung zu onkolytische Viren</td></tr><tr><td>L01XX71 (Tisagenlecleucel)</td><td><a href="http://hl7.org/fhir/R4/codesystem-concept-map-equivalence.html#concept-map-equivalence-equivalent" title="equivalent">is equivalent to</a></td><td>L01XL04 (Tisagenlecleucel)</td><td>Reklassifizierung zu CAR-T-Zelltherapien</td></tr></table></div>
  </text>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability">
    <valueCode value="shareable"/>
  </extension>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability">
    <valueCode value="publishable"/>
  </extension>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/artifact-versionPolicy">
    <valueCodeableConcept>
      <coding>
        <system
                value="http://terminology.hl7.org/CodeSystem/artifact-version-policy-codes"/>
        <code value="package"/>
        <display value="Package"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/resource-approvalDate">
    <valueDate value="2026-09-15"/>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/artifact-topic">
    <valueCodeableConcept>
      <coding>
        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
        <code value="C3262"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/artifact-author">
    <valueContactDetail>
      <telecom>
        <system value="email"/>
        <value value="thomas.debertshaeuser@charite.de"/>
      </telecom>
    </valueContactDetail>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/artifact-editor">
    <valueContactDetail>
      <name value="Taskforce Core Data Set"/>
    </valueContactDetail>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/artifact-reviewer">
    <valueContactDetail>
      <name value="Interoperability Working Group"/>
      <telecom>
        <system value="url"/>
        <value
               value="https://www.medizininformatik-initiative.de/en/collaboration/interoperability-working-group"/>
      </telecom>
    </valueContactDetail>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/artifact-reviewer">
    <valueContactDetail>
      <name value="National Steering Committee"/>
      <telecom>
        <system value="url"/>
        <value
               value="https://www.medizininformatik-initiative.de/en/collaboration/national-steering-committee"/>
      </telecom>
    </valueContactDetail>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/artifact-endorser">
    <valueContactDetail>
      <name value="Interoperability Working Group"/>
      <telecom>
        <system value="url"/>
        <value
               value="https://www.medizininformatik-initiative.de/en/collaboration/interoperability-working-group"/>
      </telecom>
    </valueContactDetail>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/artifact-endorser">
    <valueContactDetail>
      <name value="National Steering Committee"/>
      <telecom>
        <system value="url"/>
        <value
               value="https://www.medizininformatik-initiative.de/en/collaboration/national-steering-committee"/>
      </telecom>
    </valueContactDetail>
  </extension>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/artifact-versionAlgorithm">
    <valueCoding>
      <system value="http://hl7.org/fhir/version-algorithm"/>
      <code value="semver"/>
      <display value="SemVer"/>
    </valueCoding>
  </extension>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/resource-effectivePeriod">
    <valuePeriod>
      <start value="2027"/>
    </valuePeriod>
  </extension>
  <url
       value="https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ConceptMap/mii-cm-onko-atc-transitions-2023"/>
  <version value="2027.0.0-ballot.1"/>
  <name value="MII_CM_Onko_ATC_Transitions_2023"/>
  <title value="MII CM Onko ATC Code Changes 2022 to 2023"/>
  <status value="active"/>
  <experimental value="false"/>
  <date value="2024-12-12"/>
  <publisher value="Medizininformatik Initiative"/>
  <contact>
    <name value="Medizininformatik Initiative"/>
    <telecom>
      <system value="url"/>
      <value value="https://www.medizininformatik-initiative.de/"/>
    </telecom>
  </contact>
  <description
               value="Diese ConceptMap dokumentiert die ATC-Code-Änderungen von 2022 zu 2023. In diesem Jahr wurden CAR-T-Zelltherapien und onkolytische Viren in neue spezifische ATC-Kategorien umklassifiziert."/>
  <jurisdiction>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="DE"/>
      <display value="Germany"/>
    </coding>
  </jurisdiction>
  <purpose
           value="Migration von ATC-Codes für CAR-T-Zelltherapien und onkolytische Viren, die 2023 umkodiert wurden."/>
  <sourceCanonical
                   value="https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-systemische-therapie-substanzen-2022"/>
  <targetCanonical
                   value="https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-systemische-therapie-substanzen-2023"/>
  <group>
    <source value="http://fhir.de/CodeSystem/bfarm/atc"/>
    <target value="http://fhir.de/CodeSystem/bfarm/atc"/>
    <element>
      <code value="L01XX70"/>
      <display value="Axicabtagen Ciloleucel"/>
      <target>
        <code value="L01XL03"/>
        <display value="Axicabtagen Ciloleucel"/>
        <equivalence value="equivalent"/>
        <comment value="Reklassifizierung zu CAR-T-Zelltherapien"/>
      </target>
    </element>
    <element>
      <code value="L01XX51"/>
      <display value="Talimogen laherparepvec"/>
      <target>
        <code value="L01XL02"/>
        <display value="Talimogen laherparepvec"/>
        <equivalence value="equivalent"/>
        <comment value="Reklassifizierung zu onkolytische Viren"/>
      </target>
    </element>
    <element>
      <code value="L01XX71"/>
      <display value="Tisagenlecleucel"/>
      <target>
        <code value="L01XL04"/>
        <display value="Tisagenlecleucel"/>
        <equivalence value="equivalent"/>
        <comment value="Reklassifizierung zu CAR-T-Zelltherapien"/>
      </target>
    </element>
  </group>
</ConceptMap>